Literature DB >> 27007481

Detection of in Vitro Metabolite Formation of Leflunomide: A Fluorescence Dynamics and Electronic Structure Study.

Poornima Sharma1, Debraj Gangopadhyay1, Phool Chand Mishra1, Hirdyesh Mishra2, Ranjan K Singh1.   

Abstract

The metabolic transformation of antirheumatic fluorescent drug leflunomide into its active metabolite teriflunomide through isoxazole ring opening has been monitored in vitro using steady state and time domain fluorescence spectroscopy and density functional theory. During metabolic reaction, absorption of leflunomide split into two bands resembling absorption spectra of teriflunomide. The fluorescence spectra reveal slow conversion of leflunomide to E and Z forms of teriflunomide in aqueous medium, which becomes faster at basic pH. The E form, which is more potent as a drug, becomes more stable with an increase in the basicity of the medium. Both molecules are associated with charge transfer due to twisting in the lowest singlet excited state. Excited state charge transfer followed by proton transfer was also observed in the Z form during the ring opening of leflunomide. Quantum yield and radiative decay rates have been observed to decrease for the metabolite because of an increase in nonradiative decay channels.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27007481     DOI: 10.1021/acs.jmedchem.6b00088

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis.

Authors:  Kin Man Au; Roland Tisch; Andrew Z Wang
Journal:  Adv Mater       Date:  2021-12-13       Impact factor: 30.849

2.  Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors.

Authors:  Sona Hubackova; Eliska Davidova; Stepana Boukalova; Jaromira Kovarova; Martina Bajzikova; Ana Coelho; Mikkel G Terp; Henrik J Ditzel; Jakub Rohlena; Jiri Neuzil
Journal:  Cell Death Dis       Date:  2020-02-07       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.